Cargando…
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
Epidemiological evidences suggested that 5-aminosalicylic acid (5-ASA) therapy may prevent the development of colorectal cancer in inflammatory bowel disease patients. Our aim is to investigate whether peroxisome proliferator-activated receptor-γ (PPARγ) mediates the antineoplastic effects of 5-ASA....
Autores principales: | Rousseaux, Christel, El-Jamal, Noura, Fumery, Mathurin, Dubuquoy, Caroline, Romano, Olivier, Chatelain, Denis, Langlois, Audrey, Bertin, Benjamin, Buob, David, Colombel, Jean Frederic, Cortot, Antoine, Desreumaux, Pierre, Dubuquoy, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810841/ https://www.ncbi.nlm.nih.gov/pubmed/23843037 http://dx.doi.org/10.1093/carcin/bgt245 |
Ejemplares similares
-
Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
por: Fumery, Mathurin, et al.
Publicado: (2017) -
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ
por: Rousseaux, Christel, et al.
Publicado: (2005) -
GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro
por: Speca, Silvia, et al.
Publicado: (2021) -
Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2011) -
Colonic Inflammation in Mice Is Improved by Cigarette Smoke through iNKT Cells Recruitment
por: Montbarbon, Muriel, et al.
Publicado: (2013)